PerkinElmer Announces Exclusive Agreement With Leeds Innovations, Ltd.; Leaders in Prenatal Screening Team Up to Build Next Generation Screening Solution.Business Editors and Health/Medical Writers BOSTON--(BW HealthWire)--Oct. 16, 2001 PerkinElmer Life Sciences, a leading provider of drug discovery, life science research and genetic disease screening solutions, today announced a worldwide, exclusive agreement with Leeds Innovations, Ltd., a UK-based company specializing in test interpretation and decision support software for prenatal prenatal /pre·na·tal/ (-na´tal) preceding birth. pre·na·tal adj. Preceding birth. Also called antenatal. prenatal preceding birth. screening. Under the terms of the agreement, PerkinElmer Life Sciences will incorporate its Prenatal LifeCycle Screening Management software, part of PerkinElmer's Specimen Gate Laboratory Information Management System (LIMS LIMS Laboratory Information Management System LIMS Library Information Management System LIMS Limb Infrared Monitor of the Stratosphere LIMS Land Information Management System (Canada) LIMS Logistics Information Management System ) with the Leeds Innovations independently validated eLipse prenatal risk assessment module. Combined, this next-generation genetic disease screening solution automates prenatal and neonatal screening neonatal screen Pediatrics A low-cost test performed on newborn infants to identify potentially treatable diseases; most NSs can be performed on minimal amounts of blood or urine. Cf Neonatal panel/profile. programs, improving efficiency and effectiveness. This combined solution was first implemented in the Leeds Screening Laboratory and will be rolled out in additional screening laboratories worldwide. "PerkinElmer is dedicated to developing products and solutions in the emerging areas of bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the and health informatics Health informatics or medical informatics is the intersection of information science, computer science and health care. It deals with the resources, devices and methods required to optimize the acquisition, storage, retrieval and use of information in health and biomedicine. ," said John J. Engel, Executive Vice President of PerkinElmer Inc. and President of PerkinElmer Life Sciences. "We are working with Leeds Innovations to provide a best-in-class solutions package for screening laboratories worldwide. This agreement further demonstrates PerkinElmer Life Sciences' commitment to providing our customers with the most advanced technology and dependable services on the market." PerkinElmer's Specimen Gate system is an easy-to-use, laboratory information management system designed to accommodate multiple laboratory configurations with the built-in flexibility to adapt local models for genetic disease screening. The system provides total laboratory information, workflow The automatic routing of documents to the users responsible for working on them. Workflow is concerned with providing the information required to support each step of the business cycle. management and seamless instrument integration. Both the Specimen Gate system and the LifeCycle management software are based on cutting-edge computer technology that enable increased throughput, customizable workflow and centralized cen·tral·ize v. cen·tral·ized, cen·tral·iz·ing, cen·tral·iz·es v.tr. 1. To draw into or toward a center; consolidate. 2. quality control, ultimately making screening more cost efficient and effective. The eLipse prenatal screening engine is an advanced risk assessment module equipped with the latest object-oriented software techniques and the flexibility to link into any clinical analytical system. "PerkinElmer Life Sciences is working with Leeds Innovations to provide prenatal screening laboratories with a more reliable and rigorous screening procedure by automating the entire screening process," said Ann-Christine Sundell, General Manager, PerkinElmer Genetic Disease Screening. "Our system solution is superior to other methods currently available in improving risk calculation, increasing specificity of prenatal screening and delivering a higher detection rate." About PerkinElmer Life Sciences PerkinElmer Life Sciences is a global provider of drug discovery, research, and clinical screening products, services and technologies for the life science industry. Incorporating the NEN Nen, river, China Nen (nŭn) or Nonni (nôn`nē), river, 740 mi (1,191 km) long, rising in the Yilehuli (Ilkuri) Mts., N Heilongjiang prov. (R), Wallac(TM), and Receptor Biology(TM) product brands, PerkinElmer Life Sciences offers a complete line of instrumentation, reagents and consumables, as well as assay development and instrumentation systems for high throughput screening, and other areas involved in target validation See validate. validation - The stage in the software life-cycle at the end of the development process where software is evaluated to ensure that it complies with the requirements. for drug discovery. For more information, contact: PerkinElmer Life Sciences 549 Albany Street, Boston, MA, 02118, USA; Telephone: (800) 551-2121 (U.S. Only) or +1 (617) 482-9595; Fax: +1 (617) 482-1380. Website: www.perkinelmer.com/lifesciences. PerkinElmer, Inc. reported annual revenues of $1.7 billion in 2000. The high technology Company, based in Boston, Massachusetts “Boston” redirects here. For other uses, see Boston (disambiguation). Boston is the capital and most populous city of Massachusetts.[3] The largest city in New England, Boston is considered the unofficial economic and cultural center of the entire New , operates in four businesses - Life Sciences, Optoelectronics See optoelectronic. , Instruments, and Fluid Sciences. The Company has operations in over 125 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com or at 1-877-PKI-NYSE. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion